[HTML][HTML] Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
Background Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …
[HTML][HTML] Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
N Daniels, M Moerkerke, J Steyaert, A Bamps… - Molecular …, 2023 - ncbi.nlm.nih.gov
Background Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …
Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
N Daniels, M Moerkerke, J Steyaert… - Molecular …, 2023 - search.ebscohost.com
Background: Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …
[HTML][HTML] Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
N Daniels, M Moerkerke, J Steyaert… - Molecular …, 2023 - molecularautism.biomedcentral.com
Intranasal administration of oxytocin is increasingly explored as a new approach to facilitate
social development and reduce disability associated with a diagnosis of autism spectrum …
social development and reduce disability associated with a diagnosis of autism spectrum …
Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
N Daniels, M Moerkerke, J Steyaert… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …
Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
N Daniels, M Moerkerke, J Steyaert, A Bamps… - Molecular …, 2023 - search.proquest.com
Background Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …
Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
N Daniels, M Moerkerke, J Steyaert, A Bamps… - Molecular …, 2023 - europepmc.org
Background Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …
Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
N Daniels, M Moerkerke, J Steyaert, A Bamps… - Molecular …, 2023 - lirias.kuleuven.be
BACKGROUND: Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …
Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
N Daniels, M Moerkerke, J Steyaert, A Bamps… - Molecular …, 2023 - europepmc.org
Background Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …
[PDF][PDF] Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial
N Daniels, M Moerkerke, J Steyaert, A Bamps… - 2023 - molecularautism.biomedcentral.com
Background Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …
approach to facilitate social development and reduce disability associated with a diagnosis …